Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Type 2 diabetics treated with rosiglitazone are at increased risk of heart failure events, researchers report in the January 29th online issue of…
NEW YORK (Reuters Health) – Limiting thyroid tests to high-risk women will miss most cases of thyroid dysfunction during pregnancy, randomized trial results show. Furthermore, when low-risk women…
NEW YORK (Reuters Health) – Patients with Huntington’s disease treated with the investigational drug latrepirdine (dimebon) showed signs of improved cognitive function in a 3-month trial, investigators report.…
NEW YORK (Reuters Health) – Triple antiplatelet therapy is more effective than dual therapy at reducing ischemic events after implantation of a drug-eluting stent (DES), according to an…
NEW YORK (Reuters Health) – Potassium monitoring can help prevent drug-associated hyperkalemia events in patients with diabetes, according to a report in the January 20th online issue of…
NEW YORK (Reuters Health) – How intermittent pneumatic compression compares to graduated compression stockings for preventing deep vein thrombosis (DVT) is still unclear, according to a systematic review…
NEW YORK (Reuters Health) – For acute gout flare, a 1-hour low-dose oral colchicine regimen offers comparable efficacy and better tolerability than the more common 6-hour high-dose regimen,…
Program Overview The Best Practice Series in Atherosclerosis is a series of 5-minute videos featuring top physicians discussing the best ways to diagnose and treat atherosclerosis based on…
NEW YORK (Reuters Health) – In patients with peptic ulcers, eradication of Helicobacter pylori seemed to double the risk of new-onset reflux – but only in cohort study…
NEW YORK (Reuters Health) – Although inhaled corticosteroids (ICS) can help prevent exacerbations of chronic obstructive pulmonary disease (COPD), an analysis of randomized trials suggests that the benefits…
